Asia / TAIWAN
Company Overview
HanchorBio inc develops biological medicines with simultaneous multi-targeting through a novel IGG FC-based designer biologics platform. The company was founded by Scott Liu on November 11, 2020 and is headquartered in Taipei, Taiwan.
HanchorBio inc develops biological medicines with simultaneous multi-targeting through a novel IGG FC-based designer biologics platform. The company was founded by Scott Liu on November 11, 2020 and is headquartered in Taipei, Taiwan.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Pharmaceuticals & Biotechnology |
| Sub Industry | Biological Products Exc. Diagnostic |
| Country | TAIWAN |
| Employees | n/a |
| Reporting Unit | Billions |
| Primary Exchange | TAI |
| Instrument Type | Equity |
| Wright ID | C158N6WV5 |
Key Metrics
| Current price | $130.00 |
| Market cap | $18.32 B |
| P/E ratio | n/a |
| Common shares | 140.9 M |
| Closely held | 87.7 M |
| Share type | Gu |
| Quality rating | LBD0 |
| Dividend yield | 0.00% |
Recent stock performance
| 1 Week | -4.1% |
| 4 Week | -22.2% |
| 13 Week | -8.8% |
Officers
n/a
Address
TAIWAN
| Phone | n/a |
Quarterly Earnings & Dividends
Quarterly earnings and dividend history is not available for this company.
Try another report for annual statements, Wright Quality history or comparative analysis.